[{"Assets_0_FY_USD":390102000.0,"CommonStockSharesOutstanding_0_FY_shares":47002488.0,"EarningsPerShareBasic_1_FY_USD":-0.25,"EarningsPerShareBasic_4_FY_USD":-1.05,"EarningsPerShareDiluted_1_FY_USD":-0.25,"EarningsPerShareDiluted_4_FY_USD":-1.05,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-33683000.0,"NetIncomeLoss_1_FY_USD":-11843000.0,"NetIncomeLoss_4_FY_USD":-48925000.0,"StockholdersEquity_0_FY_USD":282046000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":46817756.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":46817756.0,"Ticker":"XNCR","CIK":"1326732","name":"XENCOR INC","OfficialName":"Xencor Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574633486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180228"}]